150 related articles for article (PubMed ID: 9579879)
1. The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery.
Sowade O; Messinger D; Franke W; Sowade B; Scigalla P; Warnke H
Eur J Haematol; 1998 Apr; 60(4):252-9. PubMed ID: 9579879
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patients.
Sowade O; Sowade B; Brilla K; Franke W; Stephan P; Gross J; Scigalla P; Warnke H
Am J Hematol; 1997 Jun; 55(2):89-96. PubMed ID: 9209004
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of erythropoietic activity on the basis of the red cell and reticulocyte distribution widths during epoetin beta therapy in patients undergoing cardiac surgery.
Sowade O; Sowade B; Gross J; Brilla K; Ziemer S; Franke W; Stephan P; Scigalla P; Warnke H
Acta Haematol; 1998; 99(1):1-7. PubMed ID: 9490558
[TBL] [Abstract][Full Text] [Related]
4. Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery.
Sowade O; Warnke H; Scigalla P; Sowade B; Franke W; Messinger D; Gross J
Blood; 1997 Jan; 89(2):411-8. PubMed ID: 9002942
[TBL] [Abstract][Full Text] [Related]
5. Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin.
Rohling RG; Zimmermann AP; Breymann C
J Hematother Stem Cell Res; 2000 Aug; 9(4):497-500. PubMed ID: 10982248
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy.
Biesma DH; Van de Wiel A; Beguin Y; Kraaijenhagen RJ; Marx JJ
Eur J Clin Invest; 1994 Jun; 24(6):426-32. PubMed ID: 7957497
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
[TBL] [Abstract][Full Text] [Related]
8. [The perioperative use of recombinant erythropoietin (rhEPO) in Jehovah's witnesses].
Soukup J; Menzel M; Roth S; Radke J
Anaesthesist; 1996 Aug; 45(8):745-9. PubMed ID: 8967587
[TBL] [Abstract][Full Text] [Related]
9. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of oxygen availability with oxygen status algorithm in patients undergoing open heart surgery treated with epoetin beta.
Sowade O; Gross J; Sowade B; Warnke H; Franke W; Messinger D; Scigalla P; Lun A; Glatzel E
J Lab Clin Med; 1997 Jan; 129(1):97-105. PubMed ID: 9011596
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial.
Feagan BG; Wong CJ; Kirkley A; Johnston DW; Smith FC; Whitsitt P; Wheeler SL; Lau CY
Ann Intern Med; 2000 Dec; 133(11):845-54. PubMed ID: 11103054
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
[TBL] [Abstract][Full Text] [Related]
13. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial.
Olijhoek G; Megens JG; Musto P; Nogarin L; Gassmann-Mayer C; Vercammen E; Hayes-Licitra SA
Transfusion; 2001 Jul; 41(7):957-63. PubMed ID: 11452166
[TBL] [Abstract][Full Text] [Related]
14. The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery.
Sowade O; Ziemer S; Sowade B; Franke W; Messinger D; Ziebell E; Scigalla P; Warnke H
J Lab Clin Med; 1997 Mar; 129(3):376-83. PubMed ID: 9042823
[TBL] [Abstract][Full Text] [Related]
15. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake.
Bechensteen AG; Hågå P; Halvorsen S; Liestøl K; Lindemann R; Whitelaw A; Tølløfsrud PA; Daae L; Thorstensen K; Sundal E
Eur J Pediatr; 1997 Jan; 156(1):56-61. PubMed ID: 9007493
[TBL] [Abstract][Full Text] [Related]
16. Investigation on the feasibility of large-volume autologous red blood cells donation: A pilot trial in a small cohort of Chinese.
Wu J; Chen G; Wang L; Wang P; Han Y; Yang L; Ouyang X
J Clin Apher; 2023 Aug; 38(4):447-456. PubMed ID: 36950971
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery.
Schmoeckel M; Nollert G; Mempel M; Mempel W; Reichart B
Thorac Cardiovasc Surg; 1993 Dec; 41(6):364-8. PubMed ID: 8128466
[TBL] [Abstract][Full Text] [Related]
18. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery.
Madi-Jebara SN; Sleilaty GS; Achouh PE; Yazigi AG; Haddad FA; Hayek GM; Antakly MC; Jebara VA
J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):59-63. PubMed ID: 14973801
[TBL] [Abstract][Full Text] [Related]
19. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
20. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
